- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02973425
Take a Break (TAB): mHealth-assisted Skills Building Challenge for Unmotivated Smokers
Study Overview
Status
Conditions
Detailed Description
The Take a Break intervention is designed to increase self-efficacy and support new skills for Motivation Phase smokers. We hypothesize that, compared with the NRT-only group, the Take a Break group will have a greater number of days abstinent during the 'break' period, a greater increase in self-efficacy at the end of the 'break' period, a lower time to first quit attempt, and a higher rate of quit at 6 months. This research study will also provide valuable insight into this population of smokers and increase our understanding of which tools may be effective in helping them quit smoking Our Specific Aims are
- AIM 1: Refine the Take a Break mHealth tool and implementation program.
- AIM 2: Conduct a randomized trial of the effectiveness of Take a Break.
- AIM 3: Follow participants in the AIM 2 randomized clinical trial for 6 months to evaluate time to quit attempts, number of quit attempts, and 6-month biochemically verified point prevalent cessation.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Worcester, Massachusetts, United States, 01655
- University of Massachusetts Medical School
-
Worcester, Massachusetts, United States, 01605
- Reliant Medical Group
-
Worcester, Massachusetts, United States, 01605
- VA Central Western Massachusetts Healthcare System
-
-
New York
-
Great Neck, New York, United States, 11030
- Northwell Health
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- For all Aims, investigators will include individuals 18 years and older who are identified as current smokers who are not preparing to quit, and are active in care within the UMMHC system, Northwell Health in Long Island, NY, Reliant Medical Group (RMG) in Worcester, MA and Central Western Massachusetts VA (VACWM) in Worcester, MA. Active in care is defined as having at least two clinical visits in the past year. If an eligible participant does not already have a smart phone, one will be provided to them, free of charge, for the duration of their participation in the study.
Exclusion Criteria:
- Exclusion Criteria: Those unwilling to sample nicotine lozenges or participate in the game will be excluded. All patients already on NRT will be excluded. All participants who have a FDA contraindication or cautions for nicotine lozenge use (pregnancy, breastfeeding, recent cardiovascular distress, or phenylketonuria) will be excluded. We have chosen to exclude patients with a diagnosis of depression, due to confounding factors.
Adults unable to consent, individuals who are not yet adults (infants, children, teenagers), and prisoners will be excluded from this study. The Food and Drug Administration (FDA) advises caution for nicotine lozenge use among women who are pregnant. Thus, women who are pregnant at the time of baseline will be excluded from the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: NRT and mHealth assessment tool without feedback
For the comparison group, implementation will be balanced in all variables except the Take a Break Intervention. The investigators will balance the two groups further by having the comparison (NRT-Sampling group) complete mHealth assessments (without feedback or goal-setting) as an attention control. Participants randomized to the comparison group will only have access to a mHealth assessment tool similar to the "Challenge Quizzes" but without feedback. |
NRT and mHealth assessment tool without feedback
|
Experimental: Take a Break as an augmentation to NRT in Motivation
The Intervention: Take a Break as an augmentation to NRT-sampling in Motivation Phase.
Take a Break is an intervention in which smokers are encouraged to engage in smoking abstinence.
The main element, the "Break," is a two-week challenge where smokers report days they are smoke-free.
The Break is preceded by a 1-week training challenge where Challenge Quizzes (ecological momentary assessments) collect information to guide the smokers during the Break.
At baseline, all smokers will be provided NRT lozenges for sampling.
At weeks 1 and 3 of the "Marathon", our Tobacco Treatment Specialist will call all smokers, assess their experiences and collect data.Participants in the intervention will receive the full tool suite.
|
NRT sampling experience & Suite of mHealth motivational tools and mini-games.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time to First Quit Attempt
Time Frame: 6 months
|
Time to first quit attempt is measured by participant self-report of number of days from baseline to first quit attempt within a 6 month period.
At the 6-month follow-up visit, the dates of all quit attempts were assessed using the Timeline Follow-Back Method and used to calculate time to first quit attempt.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Self-Efficacy at the End of the 6 Months
Time Frame: 6 months
|
Self Efficacy is measured by the Self-Efficacy Questionnaire (SEQ-12).The SEQ-12 is a 12-item instrument (two six-item subscales) that measures the confidence in ability to refrain from smoking when facing internal stimuli (e.g. feeling depressed) and external stimuli (e.g. being with smokers). The scale varies from 1-5 [Not at all (1) Not very(2) Moderately(3) Very (4) Extremely (5)] A higher score indicates a higher level of confidence to refrain from smoking in certain social or emotional situations and a lower score indicates a lower level of confidence to refrain from smoking. |
6 months
|
Point Prevalent Cessation as Measured by Carbon Monoxide Levels
Time Frame: 6 months
|
Point prevalent cessation here is measured by the number of participants with a decreased carbon monoxide level as verified by carbon monoxide levels in blood.
|
6 months
|
Mean Number of Days Abstinent During the First 3 Weeks
Time Frame: 3 Weeks
|
Measure the mean number of days abstinent as self-reported by participant via the mHealth assessment.
|
3 Weeks
|
Number of Participants Abstinent During the First 3 Weeks
Time Frame: 3 Weeks
|
Number of participants abstinent within the 3 week period as self-reported by participant via the mHealth assessment. . |
3 Weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants Completing Daily Challenge Quiz
Time Frame: 3 weeks
|
Participants were asked to complete daily challenge quizzes during the first 3 weeks of participation.
The challenge quizzes contained daily self-assessment text messages and motivational replies (intervention only)
|
3 weeks
|
Number of Participants Completing a Call With Study Team to Establish a Smoking Abstinence Goal.
Time Frame: 1 week
|
Participants in the Intervention group were asked to participate in a goal-setting call to establish a smoking abstinence goal (typically one to two days of abstinence from cigarettes).
The outcome measures the number of participants who completed to goal-setting call.
|
1 week
|
Number of Participants Use of Mobile Health Application (mHealth App) to Manage Nicotine Cravings.
Time Frame: 3 week
|
TAB participants were encouraged to use mHealth apps that provide relaxation or distraction to help manage smoking cravings.
The study team measured the number of participants used mHealth apps to manage nicotine cravings in a 3 week period.
|
3 week
|
Number of TAB Participants Setting a Brief Abstinence Goal With the TTS (Tobacco Treatment Specialist)
Time Frame: 2 week
|
At one week TAB participants were asked to whether they would like to set an abstinence goal for the following 2-week challenge.
The outcome measures the number of participants in the TAB group who set a brief abstinence goal
|
2 week
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Rajani S Sadasivam, PhD, UMMS
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- H00007427
- R01CA190866-01A1 (U.S. NIH Grant/Contract)
- R25CA172009-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking Cessation
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
Nabi BiopharmaceuticalsNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco CessationUnited States
-
Heidelberg UniversityPfizerTerminatedSmoking | Smoking Cessation | Tobacco Use CessationGermany
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
University of MiamiFlorida Department of HealthRecruitingSmoking Cessation | Tobacco Smoking | Tobacco Use CessationUnited States
-
The University of Hong KongNot yet recruitingSmoking Cessation Counseling Ability | Smoking Cessation Counseling PracticeHong Kong
-
University of ChicagoNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)Completed
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI)TerminatedSmoking | Smoking CessationUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Completed
Clinical Trials on NRT and mHealth assessment tool without feedback
-
Massachusetts General HospitalMassachusetts Institute of TechnologyUnknownObesity | Health Behavior
-
Duke UniversityAmerican Heart Association; Duke Clinical Research InstituteCompletedHeart Failure | Diabetes MellitusUnited States
-
University of Colorado, DenverNational Cancer Institute (NCI)RecruitingKidney Cancer | Leukemia | Myeloid Leukemia | Breast Cancer | Multiple Myeloma | Hodgkin Lymphoma | Prostate Cancer | Bladder Cancer | Lymphoid Leukemia | Monocytic LeukemiaUnited States
-
University of California, DavisNational Institute of Mental Health (NIMH); Washington University School of... and other collaboratorsEnrolling by invitationFirst Episode Psychosis (FEP)United States
-
Chang Gung Memorial HospitalCompleted
-
UConn HealthAgency for Healthcare Research and Quality (AHRQ)Completed
-
University of California, BerkeleyRecruiting
-
Mayo ClinicJR Albert FoundationCompleted
-
Eric KuhnUnknownPost-Traumatic Stress Disorder | Alcohol Abuse
-
Istituto Auxologico ItalianoRecruitingHealth BehaviorItaly